To a considerable extent, the IHC findings in the post-mortem PD midbrain (Fig. 1), and in the brains of end-stage M83 mice (Figs. 3, 4) implicate pathological aSyn deposition and/or aggregation as a trigger for altered p-NRF2 localization. Here, NFE2L2 is linked to Parkinson disease.